Seeking Alpha
/
Seaking Alpha -
17 hours ago
REHOVOT, Israel, May 6, 2024 /PRNewswire/ -- PractiTest, a leader in innovative test management solutions, continues to push the boundaries with the release of Milestones, a powerful project management module enabling QA teams to align and stay conne...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
SAN ANTONIO, May 6, 2024 /PRNewswire/ -- Clear Channel Outdoor Holdings, Inc., (NYSE:CCO) announced today that David Sailer, Chief Financial Officer of Clear Channel Outdoor Holdings, Inc. and Bob McCuin, Chief Revenue Officer of Clear Channel Outdoo...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
The FDA has cleared the investigational new drug (IND) application for EIS-12656, a first-in-class orally bioavailable and blood brain barrier-penetrant allosteric inhibitor of ALC1 (CHD1L), a key molecular machine in DNA repair. EIS-12656 targets ho...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
HOLON, ISRAEL, May 6, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will release its first quarter 2024 f...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
WEST VALLEY CITY, Utah, May 6, 2024 /PRNewswire/ -- Scientia Vascular, a leader in neurovascular innovation, is thrilled to announce the FDA clearance of two uniquely engineered catheters: the Plato 17—a DMSO-compatible microcatheter—and the Socrates...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
Proceeds from financing to support ongoing clinical development of lead program targeting PVR as well as IND-enabling activities for multiple ADC candidates TEL AVIV, Israel, May 6, 2024 /PRNewswire/ -- Guangzhou-Israel Biotechnology Fund (GIBF) anno...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
Fans and locals shopped the latest gear from Pacsun and Formula 1® at the Aventura, FL Pacsun store and visited the mobile pop-up truck at Smorgasburg Miami MIAMI, May 6, 2024 /PRNewswire/ -- California youth retailer, Pacsun, made a pit stop in Miam...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
The TiE50 Award win follows SucceedSmart's recognition with five Stevie® Awards and three HR Tech Awards last week LOS ALTOS, Calif., May 6, 2024 /PRNewswire/ -- SucceedSmart, the pioneer of AI-driven modern executive recruitment, was named a TiE50 A...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
- Presentation Today, Monday, May 6, 2024 in Atlanta, Georgia - TEL AVIV, Israel, May 6, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and ra...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
CHARLES TOWN, W.Va., May 6, 2024 /PRNewswire/ -- (OTC: PTBS) – BCT-Bank of Charles Town, also known as The Community's Bank, recently announced the promotion of Leslie D. Crabill to Executive Vice President, Director of BCT Wealth and Investments. Ms...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
NEW YORK, May 6, 2024 /PRNewswire/ -- MikeWorldWide, a leading independent public relations agency, is delighted to welcome Sal Della Monica as executive vice president. In a newly created position, Della Monica will operate in a hybrid capacity mana...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
SASKATOON, SK, May 6, 2024 /PRNewswire/ - IsoEnergy Ltd. ("IsoEnergy" or the "Company") (TSXV: ISO) (OTCQX: ISENF) is pleased to announce that it has commenced its 2024 exploration program in Utah, focusing on four projects: the Tony M Mine, the Rim...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
SAN ANTONIO, May 6, 2024 /PRNewswire/ -- Clear Channel Outdoor Holdings, Inc., (NYSE:CCO) announced today that David Sailer, Chief Financial Officer of Clear Channel Outdoor Holdings, Inc. and Bob McCuin, Chief Revenue Officer of Clear Channel Outdoo...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
Phase 1 study of MTX-463 initiated after FDA Clearance of IND IND-enabling studies completed for second antibody program with Phase 1 expected to start in Q3 Clinical Advisory Board (CAB) of global experts in fibrosis formed to advance clinical devel...
Seeking Alpha
/
Seaking Alpha -
17 hours ago
The new Chinese patent for opaganib as a therapy for inhibition of single-stranded RNA virus replication (notably Ebola Disease Virus) is valid through 2035 and adds to opaganib's strong global intellectual property portfolio across multiple indicati...